Xin Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xin Lu has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Huiran Yue
Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China
6 shared publicationsJun Li
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China
6 shared publicationsRuifang Chen
Present Address: Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People’s Republic of China
4 shared publicationsJieyu Wang
Obstetrics and Gynecology Hospital, Fudan University, No.419, Fangxie Road, Shanghai 200011, China.; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China
3 shared publicationsTingting Zhu
Department of Gynecology Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
3 shared publicationsWenzhi Li
Department of Gynecology, Obstetrics and Gynecology Hospital Fudan University Shanghai China
3 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Wolters Kluwer Health in Reproductive and Developmental Medicine
VPS4B mutation disrupts oocyte meiosis and is associated with pregnancy loss
Objective: Pregnancy loss represents one of the most common adverse outcomes in human reproduction, yet its genetic etiology remains incompletely understood. Our study aimed to identify novel genetic causes in patients presenting with pregnancy loss and hydatidiform mole. Methods: We recruited 80 patients with a history of adverse pregnancy outcomes. Among them, 74 patients had experienced at least one hydatidiform mole. After excluding six patients carrying pathogenic NLRP7 variants, we performed whole-exome sequencing (WES) on the remaining 74 patients. Pathological analysis was used to confirm the diagnosis of hydatidiform mole. Mechanistic studies included in vitro overexpression assays in Chinese hamster ovary cells and siRNA-mediated knockdown in mouse oocytes. Results: We identified a rare homozygous missense variant in VPS4B (c.965C>T, p.Thr322Met) in a consanguineous family. In vitro overexpression assays revealed that the mutation markedly reduced VPS4B protein expression. Knockdown of Vps4b in mouse oocytes induced profound defects in meiotic spindle architecture and chromosome alignment, with the proportion of bipolar spindles decreasing from 86.5% in controls to 18.6% in knockdown oocytes, whereas the proportion of multipolar spindles increased from 13.5% to 81.4% ( P < 0.001). The polar body extrusion rate decreased from 80.8% to 3.3% ( P < 0.001). Although fertilization rates were unaffected (65.5% vs. 70.0%; P = 0.785, not significant), VPS4B-depleted embryos exhibited spindle multipolarity (36.8% vs. 9.5%) and micronucleation (47.4% vs. 0%), indicating severe post-fertilization mitotic failure. Conclusion: The VPS4B c.965C>T variant is associated with pregnancy loss and hydatidiform mole. VPS4B dysfunction in oocytes causes meiotic defects and abnormal early embryonic development, positioning VPS4B as a candidate gene for reproductive failure. These findings extend the known functions of VPS4B to female meiosis and early embryogenesis, with potential implications for genetic counseling in affected families.
- 29 September 2026
- Published by Wolters Kluwer Health in Reproductive and Developmental Medicine
Open AccessVPS4B mutation disrupts oocyte meiosis and is associated with pregnancy loss
Objective: Pregnancy loss represents one of the most common adverse outcomes in human reproduction, yet its genetic etiology remains incompletely understood. Our study aimed to identify novel genetic causes in patients presenting with pregnancy loss and hydatidiform mole. Methods: We recruited 80 patients with a history of adverse pregnancy outcomes. Among them, 74 patients had experienced at least one hydatidiform mole. After excluding six patients carrying pathogenic NLRP7 variants, we performed whole-exome sequencing (WES) on the remaining 74 patients. Pathological analysis was used to confirm the diagnosis of hydatidiform mole. Mechanistic studies included in vitro overexpression assays in Chinese hamster ovary cells and siRNA-mediated knockdown in mouse oocytes. Results: We identified a rare homozygous missense variant in VPS4B (c.965C>T, p.Thr322Met) in a consanguineous family. In vitro overexpression assays revealed that the mutation markedly reduced VPS4B protein expression. Knockdown of Vps4b in mouse oocytes induced profound defects in meiotic spindle architecture and chromosome alignment, with the proportion of bipolar spindles decreasing from 86.5% in controls to 18.6% in knockdown oocytes, whereas the proportion of multipolar spindles increased from 13.5% to 81.4% ( P < 0.001). The polar body extrusion rate decreased from 80.8% to 3.3% ( P < 0.001). Although fertilization rates were unaffected (65.5% vs. 70.0%; P = 0.785, not significant), VPS4B-depleted embryos exhibited spindle multipolarity (36.8% vs. 9.5%) and micronucleation (47.4% vs. 0%), indicating severe post-fertilization mitotic failure. Conclusion: The VPS4B c.965C>T variant is associated with pregnancy loss and hydatidiform mole. VPS4B dysfunction in oocytes causes meiotic defects and abnormal early embryonic development, positioning VPS4B as a candidate gene for reproductive failure. These findings extend the known functions of VPS4B to female meiosis and early embryogenesis, with potential implications for genetic counseling in affected families.
- Open Access
- 7 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 6092
A CAF-Associated Stromal Remodeling Signature Links Immune Exclusion to Exhaustion-Prone CD8+ T-Cell Dysfunction in High-Grade Serous Ovarian Cancer
High-grade serous ovarian carcinoma (HGSOC) shows limited benefit from immune checkpoint blockade, partly because stromal barriers impair antitumor immunity. We developed a cancer-associated fibroblast (CAF)-associated mitochondrial metabolic and matrix-remodeling signature, termed CMMS, to characterize this immune-suppressive stromal state. CMMS integrated contractile/myCAF, extracellular matrix (ECM), and mitochondrial metabolic genes. Its clinical, metabolic, and immune relevance was evaluated in TCGA-HGSOC, independent GEO cohorts, single-cell RNA-seq datasets, and an anti-PD-L1-treated cohort, followed by cell–cell communication and experimental validation. LASSO-weighted CMMS stratified overall survival, with high CMMS indicating poorer prognosis. CMMS-high tumors exhibited ECM/TGFβ activation; associations with COL1A1, POSTN, and LOX; and a hypoxia-dominant metabolic phenotype. Mediation analysis suggested that hypoxia largely linked CMMS to glycolytic remodeling. Immune profiling revealed stromal-rich immune exclusion, checkpoint activation, and exhaustion-prone T-cell dysfunction. Single-cell analysis localized CMMS mainly to myCAF-like ECM-remodeling CAFs. In validation datasets, CMMS-high CAFs were associated with reduced CD8 abundance, increased CD8 exhaustion, and stronger matrix- and chemokine-related communication with T cells. Experiments further supported a link between TGFβ-related fibroblast activation, ECM-remodeling features, and impaired CD8+ T-cell effector function. Overall, CMMS defines a CAF-enriched fibrotic–hypoxic stromal program associated with immune exclusion-related features, exhaustion-prone T-cell dysfunction, and poor outcome in HGSOC.
- 7 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 6092
Open AccessA CAF-Associated Stromal Remodeling Signature Links Immune Exclusion to Exhaustion-Prone CD8+ T-Cell Dysfunction in High-Grade Serous Ovarian Cancer
High-grade serous ovarian carcinoma (HGSOC) shows limited benefit from immune checkpoint blockade, partly because stromal barriers impair antitumor immunity. We developed a cancer-associated fibroblast (CAF)-associated mitochondrial metabolic and matrix-remodeling signature, termed CMMS, to characterize this immune-suppressive stromal state. CMMS integrated contractile/myCAF, extracellular matrix (ECM), and mitochondrial metabolic genes. Its clinical, metabolic, and immune relevance was evaluated in TCGA-HGSOC, independent GEO cohorts, single-cell RNA-seq datasets, and an anti-PD-L1-treated cohort, followed by cell–cell communication and experimental validation. LASSO-weighted CMMS stratified overall survival, with high CMMS indicating poorer prognosis. CMMS-high tumors exhibited ECM/TGFβ activation; associations with COL1A1, POSTN, and LOX; and a hypoxia-dominant metabolic phenotype. Mediation analysis suggested that hypoxia largely linked CMMS to glycolytic remodeling. Immune profiling revealed stromal-rich immune exclusion, checkpoint activation, and exhaustion-prone T-cell dysfunction. Single-cell analysis localized CMMS mainly to myCAF-like ECM-remodeling CAFs. In validation datasets, CMMS-high CAFs were associated with reduced CD8 abundance, increased CD8 exhaustion, and stronger matrix- and chemokine-related communication with T cells. Experiments further supported a link between TGFβ-related fibroblast activation, ECM-remodeling features, and impaired CD8+ T-cell effector function. Overall, CMMS defines a CAF-enriched fibrotic–hypoxic stromal program associated with immune exclusion-related features, exhaustion-prone T-cell dysfunction, and poor outcome in HGSOC.
- Open Access
- 6 November 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (11) , e70393
Precision Diagnosis and Individualized Therapy of Non‐Gestational Choriocarcinoma Invading the Corpus Uteri and Cervix: A Case Report and Literature Review
Background: Non‐gestational choriocarcinoma (NGCC) is a rare type of malignant tumor. Primary lesions are typically detected in the ovary and rarely invade the corpus uteri and cervix. NGCC usually has a poor prognosis due to the difficulty in achieving early and accurate diagnoses because of its rarity. Case: This case described a female who was initially diagnosed with gestational choriocarcinoma and treated with EMA‐CO chemotherapy. However, subsequent short tandem repeat (STR) analysis confirmed the diagnosis as NGCC, prompting surgical intervention. Given her favorable response and after thorough communication, three additional cycles of EMA‐CO chemotherapy were recommended. At her last follow‐up, her human chorionic gonadotropin level had normalized. Conclusion: This case presents a rare instance of NGCC with simultaneous uterine and cervical involvement, confirmed by STR analysis and successfully managed with the EMA‐CO regime. It highlights the necessity of precise diagnosis and personalized treatment for effective management of this disease.
- 6 November 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (11) , e70393
Open AccessPrecision Diagnosis and Individualized Therapy of Non‐Gestational Choriocarcinoma Invading the Corpus Uteri and Cervix: A Case Report and Literature Review
Background: Non‐gestational choriocarcinoma (NGCC) is a rare type of malignant tumor. Primary lesions are typically detected in the ovary and rarely invade the corpus uteri and cervix. NGCC usually has a poor prognosis due to the difficulty in achieving early and accurate diagnoses because of its rarity. Case: This case described a female who was initially diagnosed with gestational choriocarcinoma and treated with EMA‐CO chemotherapy. However, subsequent short tandem repeat (STR) analysis confirmed the diagnosis as NGCC, prompting surgical intervention. Given her favorable response and after thorough communication, three additional cycles of EMA‐CO chemotherapy were recommended. At her last follow‐up, her human chorionic gonadotropin level had normalized. Conclusion: This case presents a rare instance of NGCC with simultaneous uterine and cervical involvement, confirmed by STR analysis and successfully managed with the EMA‐CO regime. It highlights the necessity of precise diagnosis and personalized treatment for effective management of this disease.
- Open Access
- 30 July 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1643590
Demographics, risk factors associated with malignant progression, and pregnancy outcomes of hydatidiform mole: A retrospective cohort study in Shanghai, China
Objective: This study aimed to clarify the demographics, evaluate risk factors associated with malignant progression, and assess pregnancy outcomes among patients with hydatidiform mole (HM) using a large, retrospective cohort study in Shanghai.Methods: This retrospective cohort study included patients with pathologically confirmed HM from 2019 to 2023. Descriptive analyses were performed to describe the demographic characteristics, progression to postmolar gestational trophoblastic neoplasia (pGTN), and reproductive outcomes of patients. Univariate and multivariate logistic regression analyses were conducted to evaluate risk factors and develop predictive models for pGTN.Results: Of 506 patients with HM, the average age and gestational age at diagnosis were approximately 33 years and 10 weeks, respectively. During follow-up, 42 patients (8.3%) progressed to pGTN, all achieved complete response after treatment. Univariate and multivariate analyses revealed that significant risk factors for progression to pGTN included pathological type and maximum diameter of lesions by ultrasound pre-evacuation (p < 0.05 for both). A predictive model incorporating age, β-hCG ratio (before/after evacuation), and ultrasound characteristics (uterine/lesion ratio) demonstrated optimal performance and goodness of fit. Among the 304 patients who intended to conceive, 254 had documented reproductive outcomes (follow-up rate: 83.6%). Of these, 163 patients (64.2%) achieved successful re-pregnancy, including 131 (80.4%) livebirths.Conclusion: Our study provides a comprehensive update on the demographics, risk factors associated with progression to pGTN, and reproductive outcomes of patients with HM in Shanghai. The clinical application of the predictive model needs to be further verified in a longitudinal setting.
- 30 July 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1643590
Open AccessDemographics, risk factors associated with malignant progression, and pregnancy outcomes of hydatidiform mole: A retrospective cohort study in Shanghai, China
Objective: This study aimed to clarify the demographics, evaluate risk factors associated with malignant progression, and assess pregnancy outcomes among patients with hydatidiform mole (HM) using a large, retrospective cohort study in Shanghai.Methods: This retrospective cohort study included patients with pathologically confirmed HM from 2019 to 2023. Descriptive analyses were performed to describe the demographic characteristics, progression to postmolar gestational trophoblastic neoplasia (pGTN), and reproductive outcomes of patients. Univariate and multivariate logistic regression analyses were conducted to evaluate risk factors and develop predictive models for pGTN.Results: Of 506 patients with HM, the average age and gestational age at diagnosis were approximately 33 years and 10 weeks, respectively. During follow-up, 42 patients (8.3%) progressed to pGTN, all achieved complete response after treatment. Univariate and multivariate analyses revealed that significant risk factors for progression to pGTN included pathological type and maximum diameter of lesions by ultrasound pre-evacuation (p < 0.05 for both). A predictive model incorporating age, β-hCG ratio (before/after evacuation), and ultrasound characteristics (uterine/lesion ratio) demonstrated optimal performance and goodness of fit. Among the 304 patients who intended to conceive, 254 had documented reproductive outcomes (follow-up rate: 83.6%). Of these, 163 patients (64.2%) achieved successful re-pregnancy, including 131 (80.4%) livebirths.Conclusion: Our study provides a comprehensive update on the demographics, risk factors associated with progression to pGTN, and reproductive outcomes of patients with HM in Shanghai. The clinical application of the predictive model needs to be further verified in a longitudinal setting.
- Open Access
Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer
- Open Access
- 27 April 2023
- Published by Elsevier in eClinicalMedicine
- Vol. 59, 101974
Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study
- 27 April 2023
- Published by Elsevier in eClinicalMedicine
- Vol. 59, 101974
Open AccessAnti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study
- 6 April 2023
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 55 (6) , 938-947
Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance
Antiangiogenic therapies, such as treatment with bevacizumab, display modest survival benefits in ovarian cancer (OC) patients. After a transient response, the upregulation of compensatory proangiogenic pathways and the adoption of alternative vascularization processes lead to the development of resistance. Considering the high mortality rate of OC, there is an urgent need to uncover the underlying mechanisms of antiangiogenic resistance for the development of novel and effective treatment strategies. Recent investigations have confirmed that metabolic reprogramming in the tumor microenvironment (TME) exerts an essential effect on tumor aggressiveness and angiogenesis. In this review, we provide an overview of the metabolic crosstalk between OC and the TME, highlighting the regulatory mechanisms underlying the development of antiangiogenic resistance. Metabolic interventions may interrupt this complex and dynamic interactive network, providing a promising therapeutic option to improve clinical outcome in OC patients.
- 6 April 2023
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 55 (6) , 938-947
Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance
Antiangiogenic therapies, such as treatment with bevacizumab, display modest survival benefits in ovarian cancer (OC) patients. After a transient response, the upregulation of compensatory proangiogenic pathways and the adoption of alternative vascularization processes lead to the development of resistance. Considering the high mortality rate of OC, there is an urgent need to uncover the underlying mechanisms of antiangiogenic resistance for the development of novel and effective treatment strategies. Recent investigations have confirmed that metabolic reprogramming in the tumor microenvironment (TME) exerts an essential effect on tumor aggressiveness and angiogenesis. In this review, we provide an overview of the metabolic crosstalk between OC and the TME, highlighting the regulatory mechanisms underlying the development of antiangiogenic resistance. Metabolic interventions may interrupt this complex and dynamic interactive network, providing a promising therapeutic option to improve clinical outcome in OC patients.
- 13 December 2022
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (6) , 1927-1937
Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study
To explore the differences in clinicopathological characteristics and prognosis between seromucinous borderline ovarian tumors (SMBOTs) and mucinous borderline ovarian tumors (MBOTs). Ninety-one patients with SMBOTs and MBOTs who underwent surgery at the Obstetrics and Gynecology Hospital of Fudan University from July 2006 to January 2015 were included. The median onset age of patients with SMBOTs (29 years, 20–77) was younger than that of patients with MBOTs (37 years, 16–71). SMBOTs were more likely to be exogenous and show bilateral ovarian involvement and had a smaller average tumor size of 10.63 cm, while MBOTs were more prone to endogenous growth and show unilateral involvement and had a larger average tumor size of 18.55 cm (p < 0.05). Compared with MBOTs, SMBOTs were characterized by the expression of Mullerian differentiation markers (p < 0.05). Recurrence occurred in 15.8% patients with SMBOT and 9.1% patients with MBOT. One case of SMBOT (2.6%) and one case of MBOT (2.3%) progressed to malignancy during follow-up, but no disease-related death was observed. Age less than 40 years was a risk factor for recurrence, while the effect of fertility-sparing surgery (FSS) on recurrence requires a larger sample size to be validated. The clinical characteristics of SMBOTs and MBOTs are similar but also quite different. High expression of Mullerian differentiation markers in SMBOT may indicate a better response to hormone therapy. Repeated FSS should be performed with caution and fully informed because of the risk of recurrence and progression to malignancy.
- 13 December 2022
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (6) , 1927-1937
Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study
To explore the differences in clinicopathological characteristics and prognosis between seromucinous borderline ovarian tumors (SMBOTs) and mucinous borderline ovarian tumors (MBOTs). Ninety-one patients with SMBOTs and MBOTs who underwent surgery at the Obstetrics and Gynecology Hospital of Fudan University from July 2006 to January 2015 were included. The median onset age of patients with SMBOTs (29 years, 20–77) was younger than that of patients with MBOTs (37 years, 16–71). SMBOTs were more likely to be exogenous and show bilateral ovarian involvement and had a smaller average tumor size of 10.63 cm, while MBOTs were more prone to endogenous growth and show unilateral involvement and had a larger average tumor size of 18.55 cm (p < 0.05). Compared with MBOTs, SMBOTs were characterized by the expression of Mullerian differentiation markers (p < 0.05). Recurrence occurred in 15.8% patients with SMBOT and 9.1% patients with MBOT. One case of SMBOT (2.6%) and one case of MBOT (2.3%) progressed to malignancy during follow-up, but no disease-related death was observed. Age less than 40 years was a risk factor for recurrence, while the effect of fertility-sparing surgery (FSS) on recurrence requires a larger sample size to be validated. The clinical characteristics of SMBOTs and MBOTs are similar but also quite different. High expression of Mullerian differentiation markers in SMBOT may indicate a better response to hormone therapy. Repeated FSS should be performed with caution and fully informed because of the risk of recurrence and progression to malignancy.
- 27 May 2022
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 74 (10) , 1-8
Dietary Factors and Incidence of Hydatidiform Mole: An Ecological Study
The current ecological study aims to explore the association between dietary factors and hydatidiform mole (HM) incidence in Japan and China. HM incidence in Japan gradually declined from 1970s to 1990s, while the dietary structure also changed during the same period, mainly characterized by a decrease in the consumption of cereals and an increase in the consumption of meat, eggs, and dairy products. In China, HM incidence varied by regions, and it positively correlated with the per capita intake of rice, fish and shrimp, and animal fat, as well as the proportion of GDP of primary industry; and negatively correlated with the per capita intake of wheat flour, starch and sugar, protein, and iron, and the proportion of protein in the caloric nutrients and the proportion of nonagricultural population. In partial analysis, the correlations of HM incidence with rice, fish and shrimp, iron, and the proportion of protein in caloric nutrients remained significant. Meanwhile, alcoholic beverage consumption and the proportion of empty calories in caloric food were also found to be positively correlated with HM incidence, while phosphorus consumption was negatively correlated. Our results suggested that HM incidence could be influenced by dietary factors.
- 27 May 2022
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 74 (10) , 1-8
Dietary Factors and Incidence of Hydatidiform Mole: An Ecological Study
The current ecological study aims to explore the association between dietary factors and hydatidiform mole (HM) incidence in Japan and China. HM incidence in Japan gradually declined from 1970s to 1990s, while the dietary structure also changed during the same period, mainly characterized by a decrease in the consumption of cereals and an increase in the consumption of meat, eggs, and dairy products. In China, HM incidence varied by regions, and it positively correlated with the per capita intake of rice, fish and shrimp, and animal fat, as well as the proportion of GDP of primary industry; and negatively correlated with the per capita intake of wheat flour, starch and sugar, protein, and iron, and the proportion of protein in the caloric nutrients and the proportion of nonagricultural population. In partial analysis, the correlations of HM incidence with rice, fish and shrimp, iron, and the proportion of protein in caloric nutrients remained significant. Meanwhile, alcoholic beverage consumption and the proportion of empty calories in caloric food were also found to be positively correlated with HM incidence, while phosphorus consumption was negatively correlated. Our results suggested that HM incidence could be influenced by dietary factors.
- 14 March 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (6) , 1451-1457
Management of relapsed gestational trophoblastic neoplasia: What can help to reduce the re‐recurrence rate?
Aim To explore the risk factors for re-recurrence in relapsed gestational trophoblastic neoplasia (GTN) and therapeutic approaches to reduce the re-recurrence rate. Methods Data of relapsed GTN treated in the Obstetrics and Gynecology Hospital of Fudan University from January 1, 2015, to December 31, 2020, were reviewed retrospectively. Risk factors associated with re-recurrence were analyzed using Logistic regression analysis. Results A total of 39 relapsed GTN patients were included in our study. At the time of the first relapse, 14 patients received single-agent chemotherapy and 25 patients received multi-agent chemotherapy. Surgery was performed in 19 patients. Complete remission was achieved in all of the patients. Re-recurrence occurred in 21 patients. Univariate analysis suggested that unifocal recurrence was the only factor significantly associated with re-recurrence (OR = 0.25, p = 0.04). Recurrence pattern-based subgroup analysis showed that the proportion of re-recurrence was lower in patients who received both surgery and chemotherapy compared to those who received only chemotherapy in the unifocal recurrence group (3/11 vs. 2/4), but not in the non-unifocal recurrence group (7/8 vs. 9/16). The results of the multivariate analysis showed that there was no significant difference in re-recurrence rates between the surgical approaches and that the non-unifocal recurrence pattern was an independent risk factor for re-recurrence. Conclusions For relapsed GTN with unifocal recurrence pattern, surgical removal of the lesion can effectively reduce the re-recurrence rate.
- 14 March 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (6) , 1451-1457
Management of relapsed gestational trophoblastic neoplasia: What can help to reduce the re‐recurrence rate?
Aim To explore the risk factors for re-recurrence in relapsed gestational trophoblastic neoplasia (GTN) and therapeutic approaches to reduce the re-recurrence rate. Methods Data of relapsed GTN treated in the Obstetrics and Gynecology Hospital of Fudan University from January 1, 2015, to December 31, 2020, were reviewed retrospectively. Risk factors associated with re-recurrence were analyzed using Logistic regression analysis. Results A total of 39 relapsed GTN patients were included in our study. At the time of the first relapse, 14 patients received single-agent chemotherapy and 25 patients received multi-agent chemotherapy. Surgery was performed in 19 patients. Complete remission was achieved in all of the patients. Re-recurrence occurred in 21 patients. Univariate analysis suggested that unifocal recurrence was the only factor significantly associated with re-recurrence (OR = 0.25, p = 0.04). Recurrence pattern-based subgroup analysis showed that the proportion of re-recurrence was lower in patients who received both surgery and chemotherapy compared to those who received only chemotherapy in the unifocal recurrence group (3/11 vs. 2/4), but not in the non-unifocal recurrence group (7/8 vs. 9/16). The results of the multivariate analysis showed that there was no significant difference in re-recurrence rates between the surgical approaches and that the non-unifocal recurrence pattern was an independent risk factor for re-recurrence. Conclusions For relapsed GTN with unifocal recurrence pattern, surgical removal of the lesion can effectively reduce the re-recurrence rate.